(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three most active and biggest winners today are Greenpro Capital Corp., Greencity Acquisition Corporation, and MercadoLibre.

Rank Financial Asset Price Change Updated (EST)
1 Greenpro Capital Corp. (GRNQ) 1.83 27.97% 2022-08-04 05:09:53
2 Greencity Acquisition Corporation (GRCYW) 0.03 21.29% 2022-08-04 05:08:06
3 MercadoLibre (MELI) 1033.23 15.98% 2022-08-04 14:57:56
4 BeiGene (BGNE) 193.85 14.22% 2022-08-04 14:50:57
5 Happiness Biotech Group Limited (HAPP) 0.25 13.64% 2022-08-04 07:09:51
6 EPAM Systems (EPAM) 415.01 12.16% 2022-08-04 14:59:38
7 IMAC Holdings (IMACW) 0.18 12.04% 2022-08-04 15:14:06
8 Pacific Biosciences of California (PACB) 5.82 11.61% 2022-08-04 14:58:48
9 Immatics N.V. (IMTXW) 3.61 11.08% 2022-08-04 15:49:16
10 iClick Interactive Asia Group Limited (ICLK) 0.56 10.73% 2022-08-04 13:10:06

The three most active and biggest losers today are Helius Medical Technologies, Fortinet, and Glory Star New Media Group Holdings Limited.

Rank Financial Asset Price Change Updated (EST)
1 Helius Medical Technologies (HSDT) 1.12 -28.8% 2022-08-04 09:14:05
2 Fortinet (FTNT) 52.83 -15.99% 2022-08-04 14:52:50
3 Glory Star New Media Group Holdings Limited (GSMGW) 0.02 -14.57% 2022-08-04 05:23:12
4 Immuron Limited (IMRNW) 0.07 -14.39% 2022-08-04 15:47:14
5 HighPeak Energy (HPKEW) 10.40 -13.34% 2022-08-04 09:09:05
6 Fastly (FSLY) 11.52 -12.76% 2022-08-04 14:57:06
7 Apache (APA) 30.67 -10.94% 2022-08-04 14:50:44
8 NeuroMetrix (NURO) 3.69 -10.12% 2022-08-04 14:53:23
9 Peloton (PTON) 10.50 -7.81% 2022-08-04 14:53:09
10 Cenovus Energy (CVE) 16.08 -7.75% 2022-08-04 14:58:40

Most Active Winners today

1. Greenpro Capital Corp. (GRNQ) – 27.97%

Greenpro Capital Corp. offers financial services and consulting to businesses of all sizes, primarily in Hong Kong and Malaysia. The company operates in two business segments: Service Business and Real Estate Business. It offers corporate consulting services and business consultancy, as well as tax planning and bookkeeping. The company also assists in the purchase and rental of real property properties that are available for sale or investment. It provides financial advisory services, company formation advice, company secretary, and other related support services. The company also provides services such as bank product analysis and company review; loan and credit and brokerage services; wealth planning, administration and tax planning; trusteeship, risk management and investment planning and management; as well support services for asset protection, management, consolidation and monitoring. Greenpro, Inc. was the company’s previous name. In May 2015, Greenpro Capital Corp. became Greenpro Capital Corp. Greenpro Capital Corp. was established in 2013. It is located in Hung Hom in Hong Kong.

NASDAQ ended the session with Greenpro Capital Corp. rising 27.97% to $1.83 on Thursday, after two consecutive sessions in a row of gains. NASDAQ jumped 0.41% to $12,720.58, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for Greenpro Capital Corp. is 2055570 which is 3287.39% above its average volume of 60683.

Greenpro Capital Corp.’s last close was $1.83, 92.28% under its 52-week high of $23.70.

Greenpro Capital Corp.’s Revenue

Year-on-year quarterly revenue growth declined by 2.3%, now sitting on 2.94M for the twelve trailing months.

Greenpro Capital Corp.’s Stock Yearly Top and Bottom Value

Greenpro Capital Corp.’s stock is valued at $1.83 at 17:32 EST, way below its 52-week high of $23.70 and way higher than its 52-week low of $1.28.

Greenpro Capital Corp.’s Moving Average

Greenpro Capital Corp.’s worth is way below its 50-day moving average of $2.44 and way under its 200-day moving average of $5.11.

More news about Greenpro Capital Corp..

2. Greencity Acquisition Corporation (GRCYW) – 21.29%

NASDAQ ended the session with Greencity Acquisition Corporation jumping 21.29% to $0.03 on Thursday, after five successive sessions in a row of losses. NASDAQ rose 0.41% to $12,720.58, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Greencity Acquisition Corporation’s last close was $0.03, 0% below its 52-week high of $0.03.

Greencity Acquisition Corporation’s Stock Yearly Top and Bottom Value

Greencity Acquisition Corporation’s stock is valued at $0.03 at 17:32 EST, under its 52-week high of $0.03 and way higher than its 52-week low of $0.02.

More news about Greencity Acquisition Corporation.

3. MercadoLibre (MELI) – 15.98%

MercadoLibre, Inc. runs online commerce platforms throughout Latin America. It owns MercadoLibre Marketplace which allows individuals and businesses to sell merchandise online and make sales. MercadoPago FinTech is a platform for financial technology that facilitates online transactions. Merchants can send and receive money online via the platform’s website and mobile app. They also have QR codes and points of sale that allow merchants to accept payments. It also provides MercadoFondo (an asset management tool) and MercadoCredito (a lending product). It also offers MercadoEnvios logistics solutions, where it integrates its platform with third-party logistics providers and carriers. This includes fulfillment and warehousing for sellers. The company also offers MercadoLibre Classifieds, which allows users to post their motor vehicles, boats, aircraft and other real estate, as well as services that are not available on the Marketplace. It also offers MercadoLibre Advertising Platform, which allows retailers to market their services and products on the Internet. This platform provides branding and performance marketing solutions. The company also provides MercadoShops, a software-as-a-service hosted online store solution that enables users to set-up, manage, and promote their own Webstores. The headquarters of the company are located in Buenos Aires in Argentina.

NASDAQ ended the session with MercadoLibre rising 15.98% to $1,033.23 on Thursday, after five consecutive sessions in a row of gains. NASDAQ rose 0.41% to $12,720.58, following the last session’s upward trend on what was a somewhat bullish trend trading session today.

Volume

Today’s last reported volume for MercadoLibre is 1742090 which is 146.69% above its average volume of 706166.

MercadoLibre’s last close was $890.87, 54.78% under its 52-week high of $1,970.13.

The company’s growth estimates for the current quarter and the next is 60.6% and 17.7%, respectively.

MercadoLibre’s Revenue

Year-on-year quarterly revenue growth grew by 60.5%, now sitting on 7.07B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

MercadoLibre’s stock is considered to be oversold (<=20).

MercadoLibre’s Stock Yearly Top and Bottom Value

MercadoLibre’s stock is valued at $1,033.23 at 17:32 EST, way below its 52-week high of $1,970.13 and way higher than its 52-week low of $600.68.

MercadoLibre’s Moving Average

MercadoLibre’s value is way higher than its 50-day moving average of $725.47 and under its 200-day moving average of $1,067.57.

More news about MercadoLibre.

4. BeiGene (BGNE) – 14.22%

BeiGene, Ltd. is a biotechnology company at the commercial stage. It develops and markets immuno-oncology and molecularly targeted cancer therapies in China, the United States, as well internationally. BRUKINSA is used to treat R/R classic Hodgkin’s lymphoma. Tislelizumab is used to treat R/R chronic Hodgkin’s lymphoma. REVLIMID is used to treat multiple myeloma. KYPROLIS can be used to treat multiple myeloma. BLINCYTO treats acute lymphocytic encephalopathy. SYLVANT, which treat idiopathic multifocentric castleman; and QARZIBA, to deal with neuroblastoma, Zanubrutinib is a BTK inhibitor that treats various lymphomas. Tislelizumab is an anti-PD-1 anti-cancer antibody that treats various solid and hematological tumors. Pamiparib to treat multiple myeloma; KYPROLIS to treat multiple myeloma; BLINCYTO to treat acute lymphocytic leukemia; SYLVANT to treat idiopathic multicentric castleman disease; and Sitravatinib to cure for NSCLC and other solid cancer. BGB – A333 is a PD-1 inhibitor that can be used to treat different solid tumors. BGB – A1217 is a TIGIT inhibitor that can also treat certain solid tumors. BGB – 11417 is a small molecule Bcl-2 inhibiter to help treat advanced B-cell malignancies. BGB – A445, an OX40 agonist anti-tumor antibody, will be available in clinical stages. Celgene Corporation, Merck KGaA, Mirati Therapeutics, Inc., BioAtla, Inc., Zymeworks, Inc., Atreca Inc., IGM Biosciences, Inc., and Hutchison China MediTech Limited have collaborated with the company. BeiGene, Ltd., was established in Beijing, People’s Republic of China in 2010.

NASDAQ ended the session with BeiGene jumping 14.22% to $193.85 on Thursday while NASDAQ jumped 0.41% to $12,720.58.

Volume

Today’s last reported volume for BeiGene is 220412 which is 28.83% below its average volume of 309741.

BeiGene’s last close was $169.72, 60.21% under its 52-week high of $426.56.

BeiGene’s Sales

BeiGene’s sales growth is 226.8% for the present quarter and a decline by 57.9% for the next. The company’s growth estimates for the ongoing quarter and the next is a negative 1.7% and a negative 788.4%, respectively.

BeiGene’s Revenue

Year-on-year quarterly revenue growth grew by 113.8%, now sitting on 1.18B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

BeiGene’s stock is considered to be oversold (<=20).

BeiGene’s Stock Yearly Top and Bottom Value

BeiGene’s stock is valued at $193.85 at 17:33 EST, way below its 52-week high of $426.56 and way above its 52-week low of $118.18.

BeiGene’s Moving Average

BeiGene’s value is way above its 50-day moving average of $158.33 and way under its 200-day moving average of $226.10.

More news about BeiGene.

5. Happiness Biotech Group Limited (HAPP) – 13.64%

Happiness Biotech Group Limited is engaged in research, development and manufacture of nutraceutical products and dietary supplements in China as well as internationally. Products include lucidumspore powder and cordyceps Mycelia. The company also sells ganodermalucidum products such as cleansing milk, essence oil, shampoo, conditioner, and shower gel under its Cai ZhiNing brand. It also has nourishing cream products that contain edible fungi. The company also offers COVID-19 antibody testing kits, disinfectants and non-medical facial masks. The company sells products via distributors and large-scale chain pharmacies. Happiness Biotech Group Limited, based in Nanping in the People’s Republic of China was established in 2004.

NASDAQ ended the session with Happiness Biotech Group Limited jumping 13.64% to $0.25 on Thursday while NASDAQ jumped 0.41% to $12,720.58.

Volume

Today’s last reported volume for Happiness Biotech Group Limited is 3152360 which is 78.58% above its average volume of 1765160.

Happiness Biotech Group Limited’s last close was $0.25, 80.31% under its 52-week high of $1.27.

Happiness Biotech Group Limited’s Revenue

Year-on-year quarterly revenue growth grew by 114.3%, now sitting on 96.49M for the twelve trailing months.

Happiness Biotech Group Limited’s Stock Yearly Top and Bottom Value

Happiness Biotech Group Limited’s stock is valued at $0.25 at 17:33 EST, way under its 52-week high of $1.27 and way above its 52-week low of $0.13.

Happiness Biotech Group Limited’s Moving Average

Happiness Biotech Group Limited’s worth is way higher than its 50-day moving average of $0.21 and way under its 200-day moving average of $0.42.

More news about Happiness Biotech Group Limited.

6. EPAM Systems (EPAM) – 12.16%

EPAM Systems, Inc. offers digital platform engineering services and software development in North America, Europe, Armenia, Belarus, Kazakhstan, Russia, Ukraine, Asia, as well as Australia. It offers services such as platform selection and customization, cross-platform migrating, integration, and implementation; infrastructure management services like software development and testing with private and public infrastructures. These include maintenance of application, database and server storage systems, monitoring and notification services. The company also offers operation solutions, which include integrated engineering and smart automation. It provides consulting and services for customers to improve their software testing practices and to ensure that information is not lost. The company also offers technical advice, industry experience and consulting services. It also provides digital and service design services that include strategy, design and creative services as well as product development. The company serves the travel, financial, consumer, software, hi-tech and business information, healthcare and life sciences industries. Curogram has partnered with EPAM Systems, Inc. to assist healthcare providers in implementing a COVID-19-simplified crisis response plan. Newtown, Pennsylvania is the headquarters of this company. It was established in 1993.

NYSE ended the session with EPAM Systems rising 12.16% to $415.01 on Thursday while NYSE slid 0.28% to $15,224.21.

Volume

Today’s last reported volume for EPAM Systems is 1119620 which is 74.34% above its average volume of 642201.

EPAM Systems’s last close was $370.03, 48.99% under its 52-week high of $725.40.

EPAM Systems’s Sales

EPAM Systems’s sales growth is 50.1% for the current quarter and 35.2% for the next. The company’s growth estimates for the present quarter and the next is a negative 2.2% and a negative 10.2%, respectively.

EPAM Systems’s Revenue

Year-on-year quarterly revenue growth grew by 53.1%, now sitting on 3.76B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

EPAM Systems’s stock is considered to be oversold (<=20).

EPAM Systems’s Stock Yearly Top and Bottom Value

EPAM Systems’s stock is valued at $415.01 at 17:33 EST, way below its 52-week high of $725.40 and way higher than its 52-week low of $168.59.

EPAM Systems’s Moving Average

EPAM Systems’s worth is way higher than its 50-day moving average of $316.20 and under its 200-day moving average of $430.82.

More news about EPAM Systems.

7. IMAC Holdings (IMACW) – 12.04%

NASDAQ ended the session with IMAC Holdings jumping 12.04% to $0.18 on Thursday, after five sequential sessions in a row of losses. NASDAQ rose 0.41% to $12,720.58, following the last session’s upward trend on what was a somewhat positive trend trading session today.

IMAC Holdings’s last close was $0.18, 0% under its 52-week high of $0.18.

IMAC Holdings’s Stock Yearly Top and Bottom Value

IMAC Holdings’s stock is valued at $0.18 at 17:33 EST, higher than its 52-week high of $0.18.

More news about IMAC Holdings.

8. Pacific Biosciences of California (PACB) – 11.61%

Pacific Biosciences of California, Inc. develops, manufactures, and markets sequencing systems for complex genetic problems. The single-molecule real time (SMRT), sequencing technology allows for single-molecule detection of biological processes. The company offers a range of consumable products including SMRT cell technology and various reagent kit kits for specific workflows such as template preparation in order to transform DNA into SMRTbell double stranded DNA libraries formats. This includes molecular biology reagents such as ligase buffers exonucleases, buffers and ligase. It also offers binding kits such as the modified DNA polymerase, which is used to bind SMRTbell library formats to the polymerase, in preparation to sequencing. Sequencing kits include reagents that are required to perform on-instrument real-time sequencing including the phospholinked NUCLEOTIDES. It serves commercial labs, genome centers, research institutes, genomics service providers, pharmaceutical companies, and agricultural businesses. The company markets its products via a direct sales force throughout North America and Europe as well as distribution partners across Asia, Europe and the Middle East. Asuragen and Pacific Biosciences have partnered to create assays that can be used for carrier screening, and many other purposes. They use SMRT sequencing technology. In 2005, the company, formerly called Nanofluidics, Inc., was changed to Pacific Biosciences of California, Inc. Pacific Biosciences of California, Inc., was established in 2000. It is located in Menlo Park, California.

NASDAQ ended the session with Pacific Biosciences of California jumping 11.61% to $5.82 on Thursday while NASDAQ jumped 0.41% to $12,720.58.

Volume

Today’s last reported volume for Pacific Biosciences of California is 13947400 which is 106.09% above its average volume of 6767510.

Pacific Biosciences of California’s last close was $5.21, 85.36% below its 52-week high of $35.58.

Pacific Biosciences of California’s Sales

Pacific Biosciences of California’s sales growth is 17% for the current quarter and 30.3% for the next. The company’s growth estimates for the present quarter and the next is a negative 57.1% and a negative 500%, respectively.

Pacific Biosciences of California’s Revenue

Year-on-year quarterly revenue growth grew by 32.7%, now sitting on 130.51M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Pacific Biosciences of California’s stock is considered to be oversold (<=20).

Pacific Biosciences of California’s Stock Yearly Top and Bottom Value

Pacific Biosciences of California’s stock is valued at $5.82 at 17:34 EST, way below its 52-week high of $35.58 and way above its 52-week low of $3.85.

Pacific Biosciences of California’s Moving Average

Pacific Biosciences of California’s worth is way higher than its 50-day moving average of $4.96 and way under its 200-day moving average of $13.16.

More news about Pacific Biosciences of California.

9. Immatics N.V. (IMTXW) – 11.08%

NASDAQ ended the session with Immatics N.V. jumping 11.08% to $3.61 on Thursday while NASDAQ jumped 0.41% to $12,720.58.

Immatics N.V.’s last close was $1.70, 53.55% below its 52-week high of $3.66.

Immatics N.V.’s Stock Yearly Top and Bottom Value

Immatics N.V.’s stock is valued at $3.61 at 17:34 EST, under its 52-week high of $3.66 and higher than its 52-week low of $3.45.

More news about Immatics N.V..

10. iClick Interactive Asia Group Limited (ICLK) – 10.73%

iClick Interactive Asia Group Limited and its subsidiaries offer online marketing services throughout the People’s Republic of China. It provides iAudience which allows users to identify and target their audience in order to increase brand awareness. It also offers mobile marketing solutions. These are solutions for non-search engine marketers to identify, engage and activate audience via mobile apps. They can monitor and measure results from online marketing activities through such channels. It also offers enterprise solutions, which allow clients to collect information from multiple consumer touchpoints, integrate it into one data management platform, and make sales and marketing decisions in new retail, education, real-estate, and other areas. It sells its products by entering into agreements with marketing agencies or entities, as well as marketing campaign contracts. Tencent International Business Group is a strategic partner of the company to develop Smart Retail and Smart Travel SaaS products. The original name of the company was Optimix Media Asia Limited. In March 2017, iClick Interactive Asia Group Limited became iClick Interactive Asia Group Limited. Founded in 2009, iClick Interactive Asia Group Limited is headquartered at Quarry Bay in Hong Kong.

NASDAQ ended the session with iClick Interactive Asia Group Limited rising 10.73% to $0.56 on Thursday while NASDAQ rose 0.41% to $12,720.58.

Volume

Today’s last reported volume for iClick Interactive Asia Group Limited is 195204 which is 30.31% below its average volume of 280114.

iClick Interactive Asia Group Limited’s last close was $0.51, 93.32% under its 52-week high of $7.63.

The company’s growth estimates for the present quarter and the next is a negative 300% and a negative 300%, respectively.

iClick Interactive Asia Group Limited’s Revenue

Year-on-year quarterly revenue growth declined by 28.8%, now sitting on 288.52M for the twelve trailing months.

iClick Interactive Asia Group Limited’s Stock Yearly Top and Bottom Value

iClick Interactive Asia Group Limited’s stock is valued at $0.56 at 17:34 EST, way under its 52-week high of $7.63 and way above its 52-week low of $0.50.

iClick Interactive Asia Group Limited’s Moving Average

iClick Interactive Asia Group Limited’s value is under its 50-day moving average of $0.62 and way under its 200-day moving average of $2.84.

More news about iClick Interactive Asia Group Limited.

Most Active Losers Today

1. Helius Medical Technologies (HSDT) – -28.8%

Helius Medical Technologies, Inc. is a company that develops, licenses, and acquires non-invasive technology for treating neurological diseases or trauma symptoms. The company’s product, the Portable Neuromodulation Stimulator (PoNS), a medical device that is not implantable, was designed to treat gait problems caused by multiple sclerosis or balance issues due to mild-to moderate traumatic brain injuries. It can also be used with therapeutic exercise. Newtown is the headquarters of this company.

NASDAQ ended the session with Helius Medical Technologies sliding 28.8% to $1.12 on Thursday while NASDAQ jumped 0.41% to $12,720.58.

Volume

Today’s last reported volume for Helius Medical Technologies is 1932260 which is 8.32% above its average volume of 1783800.

Helius Medical Technologies’s last close was $1.58, 90.26% under its 52-week high of $16.22.

Helius Medical Technologies’s Sales

Helius Medical Technologies’s sales growth is 407% for the current quarter and 1062.5% for the next. The company’s growth estimates for the current quarter and the next is 36.4% and 33.7%, respectively.

Helius Medical Technologies’s Revenue

Year-on-year quarterly revenue growth grew by 126.2%, now sitting on 628k for the twelve trailing months.

Helius Medical Technologies’s Stock Yearly Top and Bottom Value

Helius Medical Technologies’s stock is valued at $1.12 at 17:34 EST, way under its 52-week high of $16.22 and way higher than its 52-week low of $0.64.

Helius Medical Technologies’s Moving Average

Helius Medical Technologies’s worth is way under its 50-day moving average of $1.38 and way under its 200-day moving average of $4.36.

More news about Helius Medical Technologies.

2. Fortinet (FTNT) – -15.99%

Fortinet, Inc. offers global, automated, and integrated cybersecurity solutions. FortiGate software and hardware licenses are available. They provide a variety of security and networking functions including firewall, intrusion prevention and anti-malware. FortiSwitch is a product line that provides security solutions to connect customers’ end devices. FortiAP provides wireless networking solutions. FortiExtender appliances provide a connection to FortiGate products. FortiAnalyzer provides network analysis, monitoring, reporting, and central network logging solutions. FortiManager provides an easy-to-use and flexible management system for FortiGate products. FortiWeb is a web-based application firewall solution; FortiMail provides secure email gateway solutions; FortiSandbox technology delivers proactive detection, mitigation, and management services. FortiSIEM software family offers cloud-ready event and security management solutions. FortiToken, FortiAuthenticator, and FortiNAC are product families that provide multi-factor authentication solutions to protect assets, systems, and data. It offers security subscriptions, technical support and professional training services. The company sells security solutions through channel partners to customers within telecommunications and technology. Fortinet, Inc. offers its services and products in Europe, Asia Pacific, Africa, Middle East, Africa, Asia, and the Americas. Sunnyvale in California is where the company’s headquarters are located.

NASDAQ ended the session with Fortinet dropping 15.99% to $52.83 on Thursday, after five consecutive sessions in a row of gains. NASDAQ jumped 0.41% to $12,720.58, following the last session’s upward trend on what was a somewhat positive trend trading session today.

Volume

Today’s last reported volume for Fortinet is 18107200 which is 189.62% above its average volume of 6251990.

Fortinet’s last close was $62.88, 15.43% under its 52-week high of $74.35.

Fortinet’s Sales

Fortinet’s sales growth is 37.7% for the ongoing quarter and 38.5% for the next. The company’s growth estimates for the current quarter and the next is 15.8% and 35%, respectively.

Fortinet’s Revenue

Year-on-year quarterly revenue growth grew by 34.4%, now sitting on 3.59B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Fortinet’s stock is considered to be oversold (<=20).

Fortinet’s Stock Yearly Top and Bottom Value

Fortinet’s stock is valued at $52.83 at 17:34 EST, way under its 52-week high of $74.35 and higher than its 52-week low of $48.73.

Fortinet’s Moving Average

Fortinet’s worth is under its 50-day moving average of $58.25 and way below its 200-day moving average of $62.29.

More news about Fortinet.

3. Glory Star New Media Group Holdings Limited (GSMGW) – -14.57%

Glory Star New Media Group Limited offers content and advertising production services in China. It also operates in digital media and entertainment, as well as mobile and online advertising. It also offers CHEERS App, an ecommerce platform that provides live streaming and shopping online, along with short video, dramas, and variety shows online. Glory Star New Media Group Holdings Limited, a Beijing-based company was established in 2016.

NASDAQ ended the session with Glory Star New Media Group Holdings Limited dropping 14.57% to $0.02 on Thursday, after five consecutive sessions in a row of losses. NASDAQ jumped 0.41% to $12,720.58, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Glory Star New Media Group Holdings Limited’s last close was $0.02, 26.09% under its 52-week high of $0.02.

Glory Star New Media Group Holdings Limited’s Revenue

Year-on-year quarterly revenue growth declined by 2.7%, now sitting on 151.05M for the twelve trailing months.

Glory Star New Media Group Holdings Limited’s Stock Yearly Top and Bottom Value

Glory Star New Media Group Holdings Limited’s stock is valued at $0.02 at 17:34 EST, way under its 52-week high of $0.02 and way higher than its 52-week low of $0.01.

More news about Glory Star New Media Group Holdings Limited.

4. Immuron Limited (IMRNW) – -14.39%

NASDAQ ended the session with Immuron Limited falling 14.39% to $0.07 on Thursday, after five consecutive sessions in a row of losses. NASDAQ jumped 0.41% to $12,720.58, following the last session’s upward trend on what was a somewhat up trend exchanging session today.

Immuron Limited’s last close was $0.09, 19.79% under its 52-week high of $0.11.

Immuron Limited’s Stock Yearly Top and Bottom Value

Immuron Limited’s stock is valued at $0.07 at 17:34 EST, below its 52-week low of $0.07.

More news about Immuron Limited.

5. HighPeak Energy (HPKEW) – -13.34%

NASDAQ ended the session with HighPeak Energy dropping 13.34% to $10.40 on Thursday, after three consecutive sessions in a row of losses. NASDAQ jumped 0.41% to $12,720.58, following the last session’s upward trend on what was a somewhat positive trend exchanging session today.

Volume

Today’s last reported volume for HighPeak Energy is 278 which is 91.39% below its average volume of 3229.

HighPeak Energy’s last close was $11.95, 54.79% under its 52-week high of $26.43.

HighPeak Energy’s Stock Yearly Top and Bottom Value

HighPeak Energy’s stock is valued at $10.40 at 17:34 EST, way under its 52-week high of $26.43 and way higher than its 52-week low of $1.88.

HighPeak Energy’s Moving Average

HighPeak Energy’s value is way under its 50-day moving average of $16.52 and below its 200-day moving average of $11.14.

More news about HighPeak Energy.

6. Fastly (FSLY) – -12.76%

NYSE ended the session with Fastly dropping 12.76% to $11.52 on Thursday while NYSE slid 0.28% to $15,224.21.

Volume

Today’s last reported volume for Fastly is 6575970 which is 44.72% above its average volume of 4543700.

Fastly’s last close was $13.21, 79.38% under its 52-week high of $64.07.

The company’s growth estimates for the ongoing quarter and the next is a negative 13.3% and a negative 27.3%, respectively.

Fastly’s Revenue

Year-on-year quarterly revenue growth grew by 18.2%, now sitting on 354.33M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Fastly’s stock is considered to be oversold (<=20).

Fastly’s Stock Yearly Top and Bottom Value

Fastly’s stock is valued at $11.52 at 17:34 EST, way below its 52-week high of $64.07 and way higher than its 52-week low of $9.50.

Fastly’s Moving Average

Fastly’s value is way under its 50-day moving average of $13.58 and way under its 200-day moving average of $28.71.

More news about Fastly.

7. Apache (APA) – -10.94%

Apache Corporation is an independent energy company that explores for and develops natural gas and crude oil. It also produces natural gas liquids (NGLs) and crude oil. It has onshore operations in Permian, Midcontinent/Gulf Coast and offshore assets in the Gulf of Mexico. The company also has onshore assets located in Egypt’s Western desert and offshore assets within the North Sea, which includes the United Kingdom. The company also has an offshore exploration programme in Suriname. It had 551 million barrels crude oil reserves, 186million barrels NGLs and 1.6 trillion cubic yards of natural gas as its total proved reserves at December 31 2019. Apache Corporation was established in Houston, Texas in 1954.

NASDAQ ended the session with Apache dropping 10.94% to $30.67 on Thursday while NASDAQ jumped 0.41% to $12,720.58.

Volume

Today’s last reported volume for Apache is 10611200 which is 18.15% above its average volume of 8980770.

Apache’s last close was $34.43, 33.72% below its 52-week high of $51.95.

Apache’s Sales

Apache’s sales growth is 74.1% for the current quarter and 49.8% for the next. The company’s growth estimates for the current quarter and the next is 251.4% and 155.1%, respectively.

Apache’s Revenue

Year-on-year quarterly revenue growth grew by 90.5%, now sitting on 8.02B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Apache’s stock is considered to be overbought (>=80).

Apache’s Stock Yearly Top and Bottom Value

Apache’s stock is valued at $30.67 at 17:34 EST, way under its 52-week high of $51.95 and way above its 52-week low of $15.55.

Apache’s Moving Average

Apache’s worth is way under its 50-day moving average of $39.65 and way under its 200-day moving average of $34.95.

More news about Apache.

8. NeuroMetrix (NURO) – -10.12%

NeuroMetrix, Inc., is a healthcare company that develops and markets products to detect, diagnose, and monitor peripheral nerve and spine cord disorders. It develops neuro-stimulation therapy devices for wear and points-of-care diagnostic tests to diagnose neuropathy. This is used to treat chronic conditions such as diabetes, chronic pain and sleep disorders. The company’s most popular products are Quell which is a wearable device that provides relief from chronic, intractable, pain. This includes nerve pain caused by diabetes or lower back pain; DPNCheck, which can be used to diagnose systemic neuropathies such as diabetic peripheral nerve neuropathy. ADVANCE, an online platform, allows for traditional nerve conduction studies to be performed; and SENSUS. A pain therapy device that uses transcutaneous electrical nerve stimulation to relieve chronic, intractable, pain. It sells its products to customers, retailers, TV promotors, doctors, nurses, and other health professionals. The company operates across the United States and Mexico, as well as in Europe, Japan China, China, Middle East, Mexico, and China. GlaxoSmithKline has been a strategic partner of the company. NeuroMetrix, Inc., was established in 1996. It is located in Woburn, Massachusetts.

NASDAQ ended the session with NeuroMetrix dropping 10.12% to $3.69 on Thursday while NASDAQ rose 0.41% to $12,720.58.

Volume

Today’s last reported volume for NeuroMetrix is 226124 which is 86.47% below its average volume of 1671310.

NeuroMetrix’s last close was $4.10, 79.23% under its 52-week high of $19.74.

NeuroMetrix’s Revenue

Year-on-year quarterly revenue growth grew by 6.8%, now sitting on 8.4M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

NeuroMetrix’s stock is considered to be oversold (<=20).

NeuroMetrix’s Stock Yearly Top and Bottom Value

NeuroMetrix’s stock is valued at $3.69 at 17:34 EST, way under its 52-week high of $19.74 and way higher than its 52-week low of $2.70.

NeuroMetrix’s Moving Average

NeuroMetrix’s value is under its 50-day moving average of $3.77 and way below its 200-day moving average of $4.89.

More news about NeuroMetrix.

9. Peloton (PTON) – -7.81%

Peloton Interactive, Inc. offers interactive products for fitness in North America as well as internationally. Peloton Interactive, Inc. offers connected products such as the Peloton Bike, and the Peloton Tread. These include touchscreens that stream live classes and those on demand. Peloton Digital App for connected subscribers allows them to access its classes. It had approximately 3.0 million members as of June 30, 2020. It sells interactive fitness products through onepeloton.com and its retail stores. Peloton Interactive, Inc., was established in 2012. It is located in New York, New York.

NASDAQ ended the session with Peloton sliding 7.81% to $10.50 on Thursday while NASDAQ rose 0.41% to $12,720.58.

Volume

Today’s last reported volume for Peloton is 10227000 which is 23.37% below its average volume of 13346600.

Peloton’s last close was $11.39, 90.81% below its 52-week high of $123.94.

The company’s growth estimates for the current quarter and the next is 23.9% and 67.2%, respectively.

Peloton’s Revenue

Year-on-year quarterly revenue growth grew by 6.5%, now sitting on 4.14B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Peloton’s stock is considered to be oversold (<=20).

Peloton’s Stock Yearly Top and Bottom Value

Peloton’s stock is valued at $10.50 at 17:35 EST, way under its 52-week high of $123.94 and way higher than its 52-week low of $8.22.

Peloton’s Moving Average

Peloton’s worth is below its 50-day moving average of $11.38 and way below its 200-day moving average of $32.86.

More news about Peloton.

10. Cenovus Energy (CVE) – -7.75%

Cenovus Energy Inc. and its affiliates develop, produce, and market crude oil and natural gas liquids in Canada as well as natural gas products and services throughout the United States. It operates in three segments: Oil Sands, Deep Basin and Refining and Marketing. Oil Sands is responsible for developing and producing bitumen in northeast Alberta. Foster Creek, Christina Lake and Narrows Lake are just a few of its bitumen assets. There is also other early-stage projects. Clearwater, Kaybob-Edson and Elmworth-Wapiti are the main assets of the Deep Basin segment. There is also a variety of interests in natural gas processing plants. Refining and Marketing is responsible for transporting, selling, and refining crude oil to petroleum and other chemical products. The segment holds a half-ownership in Wood River, Borger and other refineries in the United States. It also owns an Alberta crude-by rail terminal. Cenovus Energy Inc. is located in Calgary, Canada. It was established in 2009.

NYSE ended the session with Cenovus Energy dropping 7.75% to $16.08 on Thursday while NYSE slid 0.28% to $15,224.21.

Volume

Today’s last reported volume for Cenovus Energy is 14382500 which is 36.42% above its average volume of 10542400.

Cenovus Energy’s last close was $17.43, 30.03% below its 52-week high of $24.91.

The company’s growth estimates for the current quarter and the next is 744.4% and 300%, respectively.

Cenovus Energy’s Revenue

Year-on-year quarterly revenue growth grew by 74.3%, now sitting on 53.26B for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions,

Cenovus Energy’s stock is considered to be overbought (>=80).

Cenovus Energy’s Stock Yearly Top and Bottom Value

Cenovus Energy’s stock is valued at $16.08 at 17:35 EST, way under its 52-week high of $24.91 and way above its 52-week low of $7.20.

Cenovus Energy’s Moving Average

Cenovus Energy’s value is way below its 50-day moving average of $19.99 and above its 200-day moving average of $16.03.

More news about Cenovus Energy.

Stay up to date with our winners and losers daily report

LEAVE A REPLY

Please enter your comment!
Please enter your name here